Wednesday, May 9, 2018, at 3:30 p.m. Central / 4:30 p.m. Eastern, April 11, 2018 -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference call on Wednesday, May 9, 2018, at 3:30 p.m. Central Time to discuss the company’s operating results for its first quarter ended April 1, 2018. Operating results will be released at 3:00 p.m. Central Time that day.
The live dial-in number for the call is (844) 295-9436 (U.S.) / (574) 990-1040 (Outside U.S.). The participant passcode for the call is “Wright.” A simultaneous webcast of the call will be available via Wright Medical’s corporate website at www.wright.com. The call will be archived on this site for a minimum of 12 months.
A replay of the call will be available beginning at 5:30 p.m. Central Time on May 9, 2018 through May 16, 2018. To hear this replay, dial (855) 859-2056 (U.S.) / (404) 537-3406 (Outside U.S.) and enter code 7998427.
Internet Posting of Information
Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com. The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.
About Wright Medical Group N.V.
Wright Medical Group N.V. is a global medical device company focused on extremities and biologics products. The company is committed to delivering innovative, value-added solutions improving the quality of life for patients worldwide. Wright is a recognized leader of surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics. For more information about Wright, visit www.wright.com.
Investors & Media:
Julie D. Tracy
Sr. Vice President, Chief Communications Officer
Wright Medical Group N.V.
(901) 290-5817
[email protected]


The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Amazon Secures 200 MW Wind Power Deals in Sweden
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Toyota Global Sales Fall as China Demand Slumps
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Jefferies Names AMEC Top China Semiconductor Equipment Pick
OpenAI AI Agent Swarm Behind Hugging Face Hack 



